Financials

  • Market Capitalization 3.94 B
  • Employee 192
  • Founded 2015
  • CEO N/A
  • Website www.relaytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00DSS08K9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.25
Rapporto prezzo/fatturato
94.54

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1448
ADPT
Adaptive Biotechnologies Corporation - Common Stock
25.57 USD-3.47%-15.39%+5.40%+48.15%4.08 B USD
1450
TNGX
Tango Therapeutics, Inc. - Common Stock
24.17 USD+1.51%+4.36%+0.79%+188.77%4.08 B USD
1482
ABCL
AbCellera Biologics Inc. - Common Shares
12.64 USD+0.72%-9.71%+18.46%+128.99%3.88 B USD
1493
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.29 USD+0.71%+3.01%-7.69%+78.92%3.82 B USD

Notizie